We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
77 ELEKTRONIKA

Download Mobile App




Events

31 Jul 2024 - 02 Aug 2024
02 Aug 2024 - 04 Aug 2024
20 Aug 2024 - 22 Aug 2024

UK to Invest £100 Million in Artificial Intelligence Research

By HospiMedica International staff writers
Posted on 13 Feb 2019
Print article
Image: The UK plans to invest USD 130 million on AI development for industries including life sciences (Photo courtesy of GEP).
Image: The UK plans to invest USD 130 million on AI development for industries including life sciences (Photo courtesy of GEP).
The government of the United Kingdom has announced it will invest USD 130 million to attract 1,000 new PhD placements at universities across the country to focus on artificial intelligence (AI) development, including for the life sciences industry.

During his visit to the World Economic Forum, held in Davos (Switzerland) during January 2019, the head of Her Majesty’s Treasury, Chancellor of the Exchequer Philip Hammond, said that the investment will help futureproof the UK economy, fund forthcoming research into life-saving technology to be used in national health service (NHS) hospitals, improve voice-recognition software for business and consumers, and help cities to protect their citizens from pollution hotspots by aiding development of early warning systems.

The investment in the life sciences sector will merge with other initiatives in the fields of big data and disruptive digital technologies designed to lure clinical trials which would adopt a system for analyzing study feasibility, and an application that links patients to available studies to gear up the enrolment and ensure continued investment in research and development (R&D) in the United Kingdom. The funding is part of the £7 billion committed to the modern Industrial Strategy in 2016, and is destined to elevate investment to R&D to a record level not seen since the 1970s.

“Britain is a great place to do business. We are leading the way in the tech revolution; the UK digital sector is now worth over £130 billion, with jobs growing at twice the rate of those in the wider economy,” said Chancellor Hammond. “We are backing British innovation to help create growth, more jobs and higher living standards. And we are determined, as we leave the EU, to make sure it remains that way. I want to ensure we remain the standard bearer, so we must invest in our new economy so that it can adapt and remain competitive.”

The UK modern Industrial Strategy faces four grand challenges. These include putting the UK at the forefront of the AI and data revolution, towards which a government office for AI has been established and a £9 million Centre for Data Ethics and Innovation has been built. The other three challenges include modernizing transportation through new electrical vehicle charging technologies and development and testing of connected and autonomous vehicles; maximizing opportunities from the global shifts to clean growth and low carbon innovation; and meeting the needs of an ageing society by harnessing the power of innovation.

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Extended Stay Trolley
E-MED One Day EST

Print article

Channels

Critical Care

view channel
Image: Peerbridge Cor is a 3-lead, 2-channel wireless AECG that simplifies the testing and diagnostic process (Photo courtesy of Peerbridge Health)

First-of-its-Kind Trial to Measure Ejection Fraction Severity Directly from AI-Enabled Remote ECG Wearable

Echocardiograms are a standard diagnostic tool to measure ejection fraction but require a clinical setting for administration. This can pose challenges such as scheduling delays, staffing shortages, accessibility... Read more

Surgical Techniques

view channel
Image: Fixation screws for ligament to bone repair (Photo courtesy of 4D Medicine)

Novel Biomaterial Platform Opens Up New Possibilities for Implants and Devices

Resorbable biomaterials, crucial for implantable medical devices, have seen little innovation over decades. Materials like Polylactic Acid (PLA), Polycaprolactone (PCL), and Poly Lactic-co-Glycolic Acid... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Point of Care

view channel
Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)

POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results

On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more

Business

view channel
Image: The Innovalve transseptal delivery system is designed to enable safe deployment of the Innovalve implant (Photo courtesy of Innovalve Bio)

Edwards Lifesciences Acquires Sheba Medical’s Innovalve Bio Medical

Edwards Lifesciences (Irvine, CA, USA), a leading company in medical innovations for structural heart disease and critical care, has acquired Innovalve Bio Medical LTD. (Ramat Gan, Israel), an early-stage... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.